Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
UTMD

UTMD - Utah Medical Products Inc Stock Price, Fair Value and News

67.14USD-0.22 (-0.33%)Market Closed

Market Summary

UTMD
USD67.14-0.22
Market Closed
-0.33%

UTMD Stock Price

View Fullscreen

UTMD RSI Chart

UTMD Valuation

Market Cap

236.9M

Price/Earnings (Trailing)

14.46

Price/Sales (Trailing)

4.83

EV/EBITDA

7.02

Price/Free Cashflow

11.83

UTMD Price/Sales (Trailing)

UTMD Profitability

EBT Margin

40.31%

Return on Equity

12.82%

Return on Assets

12.09%

Free Cashflow Yield

8.45%

UTMD Fundamentals

UTMD Revenue

Revenue (TTM)

49.0M

Rev. Growth (Yr)

-9.42%

Rev. Growth (Qtr)

-8.05%

UTMD Earnings

Earnings (TTM)

16.4M

Earnings Growth (Yr)

-6.12%

Earnings Growth (Qtr)

-7.72%

Breaking Down UTMD Revenue

Last 7 days

-0.4%

Last 30 days

-3.0%

Last 90 days

-3.1%

Trailing 12 Months

-29.4%

How does UTMD drawdown profile look like?

UTMD Financial Health

Current Ratio

19.57

UTMD Investor Care

Buy Backs (1Y)

2.75%

Diluted EPS (TTM)

4.5

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202449.0M000
202352.5M51.9M51.5M50.2M
202250.4M51.2M51.6M52.3M
202142.2M46.1M48.1M49.1M
202047.1M44.0M42.0M42.2M
201941.8M42.7M44.8M46.9M
201842.0M42.2M42.4M42.0M
201739.3M39.6M40.1M41.4M
201640.2M40.3M40.0M39.3M
201541.7M41.6M40.8M40.2M
201439.9M40.4M41.1M41.3M
201340.7M40.7M40.2M40.5M
201242.3M41.9M41.6M41.6M
201125.5M29.6M34.2M37.9M
2010025.7M25.4M25.1M
200900025.9M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Utah Medical Products Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 17, 2024
richins paul o
gifted
-15,687
69.72
-225
-
Jun 15, 2023
koopman brian
gifted
-5,658
94.31
-60.00
principal financial officer
May 18, 2023
richins paul o
sold
-65,429
93.47
-700
-
Mar 17, 2023
richins paul o
gifted
-13,875
92.5
-150
-
Feb 08, 2023
payne barbara a
gifted
-44,998
89.9974
-500
-
Dec 06, 2022
koopman brian
acquired
37,320
74.64
500
principal financial officer
Dec 06, 2022
koopman brian
sold (taxes)
-37,288
101
-366
principal financial officer
Nov 18, 2022
richins paul o
sold
-40,773
90.81
-449
-
Nov 17, 2022
richins paul o
sold
-14,490
90.00
-161
-

1–10 of 50

Which funds bought or sold UTMD recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 29, 2024
Clean Yield Group
reduced
-0.11
-418,634
2,255,180
0.88%
May 20, 2024
Virtu Financial LLC
new
-
317,000
317,000
0.02%
May 16, 2024
COMERICA BANK
reduced
-20.61
-3,636
7,395
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-38.94
-23,051
24,533
-%
May 16, 2024
JANE STREET GROUP, LLC
new
-
256,921
256,921
-%
May 16, 2024
Ancora Advisors LLC
sold off
-100
-1,402,850
-
-%
May 15, 2024
Man Group plc
new
-
428,296
428,296
-%
May 15, 2024
DEUTSCHE BANK AG\
unchanged
-
-30,966
167,962
-%
May 15, 2024
STATE STREET CORP
added
8.52
-523,934
5,757,770
-%
May 15, 2024
MORGAN STANLEY
added
291
2,425,370
3,477,940
-%

1–10 of 50

Are Funds Buying or Selling UTMD?

Are funds buying UTMD calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own UTMD
No. of Funds

Unveiling Utah Medical Products Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
t. rowe price investment management, inc.
7.4%
269,166
SC 13G/A
Feb 13, 2024
renaissance technologies llc
5.64%
204,614
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Jan 29, 2024
blackrock inc.
5.6%
204,421
SC 13G/A
Feb 14, 2023
t. rowe price investment management, inc.
9.4%
341,916
SC 13G
Feb 13, 2023
renaissance technologies llc
5.81%
210,614
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
4.62%
167,690
SC 13G/A
Feb 01, 2023
blackrock inc.
5.7%
205,514
SC 13G/A
Jun 10, 2022
price t rowe associates inc /md/
10.0%
365,212
SC 13G/A

Recent SEC filings of Utah Medical Products Inc

View All Filings
Date Filed Form Type Document
May 31, 2024
SD
SD
May 17, 2024
4
Insider Trading
May 10, 2024
10-Q
Quarterly Report
May 06, 2024
8-K
Current Report
Apr 25, 2024
8-K
Current Report
Apr 15, 2024
DEFA14A
DEFA14A
Apr 10, 2024
DEF 14A
DEF 14A
Mar 26, 2024
10-K
Annual Report

Utah Medical Products Inc News

Latest updates
Defense World12 Jun 202408:39 am
Yahoo Canada Finance28 May 202407:00 am
StockNews.com12 months ago

Utah Medical Products Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-8.1%11.0012.0013.0013.0013.0014.0013.0013.0012.0013.0013.0013.0011.0012.0010.009.0011.0012.0012.0012.0011.00
Gross Profit-4.7%7.007.007.008.008.008.008.008.008.008.008.008.007.007.006.005.007.008.007.008.007.00
Operating Expenses-3.00-3.003.003.00-3.003.003.00-3.003.003.00-3.003.003.00-3.003.003.00
  S&GA Expenses132.7%3.00-8.013.003.003.00-7.273.003.003.00-7.253.003.003.00-6.933.003.003.00-6.603.003.003.00
  R&D Expenses82.8%0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EBITDA Margin0.8%0.42*0.41*0.41*0.42*0.42*0.41*0.41*0.40*0.40*0.40*0.39*0.38*0.34*0.35*-------
Income Taxes15.2%1.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.000.001.001.001.00
Earnings Before Taxes-4.4%5.005.005.005.005.006.005.005.005.005.005.005.004.004.004.002.004.005.004.005.004.00
EBT Margin0.8%0.40*0.40*0.40*0.41*0.40*0.40*0.39*0.39*0.39*0.39*0.38*0.36*0.33*0.33*-------
Net Income-7.7%4.004.004.004.004.005.004.004.004.004.004.003.003.003.003.001.003.004.004.004.003.00
Net Income Margin0.8%0.33*0.33*0.33*0.33*0.33*0.32*0.31*0.31*0.30*0.30*0.29*0.28*0.25*0.26*-------
Free Cashflow0.2%5.005.005.005.007.006.005.005.005.005.006.004.006.006.00-------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets0.0%135135131130128124118116120116120117114112107104103110104103105
  Current Assets0.8%10710610299.0095.0090.0084.0079.0079.0073.0076.0071.0067.0062.0057.0053.0051.0055.0050.0046.0046.00
    Cash Equivalents1.0%94.0093.0088.0085.0081.0075.0070.0066.0066.0061.0064.0060.0056.0052.0046.0042.0040.0043.0037.0033.0033.00
  Inventory-3.6%9.0010.0010.0010.0010.009.008.007.007.007.006.006.006.006.006.007.007.007.006.008.008.00
  Net PPE-2.7%10.0011.0010.0011.0010.0010.0010.0010.0011.0011.0011.0011.0011.0011.0011.0010.0010.0011.0010.0010.0010.00
  Goodwill-0.4%14.0014.0013.0014.0014.0013.0013.0013.0014.0014.0014.0014.0014.0014.0014.0014.0014.0014.0013.0014.0014.00
Liabilities7.8%8.007.008.009.0010.0010.0010.009.0011.008.0010.009.0010.009.009.008.009.009.009.009.0013.00
  Current Liabilities16.2%5.005.004.005.006.006.006.004.006.004.005.004.005.004.004.003.004.003.004.004.007.00
Shareholder's Equity-0.4%12812812412211811410810710910711010710510398.0095.0094.0010195.0094.0092.00
  Retained Earnings0.5%139138135132129126123119118115118115113111109107107111107105102
  Additional Paid-In Capital-100.0%-1.001.000.000.000.000.00-1.001.001.000.000.000.00-0.00-0.00--0.00
Shares Outstanding-1.1%4.004.004.004.004.004.004.004.004.004.004.004.004.004.00-------
Float----313---336---286---298---327-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-1.1%5,2765,3325,1214,9136,9155,6805,5894,8325,0464,9875,9914,6925,5335,7785,0083,6775,6745,6416,3721,6833,360
  Share Based Compensation9.7%79.0072.0053.0050.0050.0062.0038.0040.0043.0043.0041.0041.0041.0039.0049.0049.0023.0028.0029.0028.0028.00
Cashflow From Investing105.6%5.00-90.00-186-320-43.00-38.00-321-222-237-253-77.00-212-10.00-54.00-95.00-257-454-288-122-118-21,012
Cashflow From Financing-271.9%-3,983-1,071-1,035-1,010-1,049-920-1,032-3,55119.00-8,070-850-1,036-949-942-1,368-1,004-7,420-969-976-1,352-930
  Dividend Payments1.7%1,0891,0711,0711,0701,0701,0511,0521,060-8,3491,0391,0391,0381,0191,0201,0351,0421,0291,0281,0281,027
  Buy Backs-2,990-------2,495-----6,976-551--6,426398--398-
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

UTMD Income Statement

2024-03-31
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME  
Sales, net$ 11,340$ 12,520
Cost of goods sold4,5744,677
Gross profit6,7667,843
Operating expense  
Selling, general and administrative2,6173,260
Research & development266144
Total operating expenses2,8833,404
Operating income3,8834,439
Other income915680
Income before provision for income taxes4,7985,119
Provision for income taxes842905
Net income$ 3,956$ 4,214
Earnings per common share (basic)$ 1.09$ 1.16
Earnings per common share (diluted)$ 1.09$ 1.16
Shares outstanding (basic)3,6183,628
Shares outstanding (diluted)3,6183,636
Other comprehensive income (loss)  
Foreign currency translation net of taxes of $0 in all periods$ (631)$ 549
Total comprehensive income$ 3,325$ 4,763

UTMD Balance Sheet

2024-03-31
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED BALANCE SHEET - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets  
Cash & Investments$ 93,808$ 92,868
Accounts & other receivables, net3,5913,391
Inventories9,2409,582
Other current assets510428
Total current assets107,149106,269
Property and equipment, net10,26610,551
Goodwill13,63813,692
Other intangible assets54,02954,296
Other intangible assets - accumulated amortization(49,641)(49,350)
Other intangible assets, net4,3884,946
Total assets135,441135,458
Current liabilities  
Accounts payable998769
Accrued expenses4,4763,941
Total current liabilities5,4744,710
Deferred tax liability - Femcare IIA9861,120
Other long term liabilities698698
Long-term lease liability285295
Deferred income taxes256322
Total liabilities7,6997,145
Stockholders' equity  
Common stock - $.01 par value; authorized - 50,000 shares; issued and outstanding - March 31, 2024, 3,588 shares and December 31, 2023, 3,628 shares3636
Accumulated other comprehensive loss(11,289)(10,658)
Additional paid-in capital0594
Retained earnings138,995138,341
Total stockholders' equity127,742128,313
Total liabilities and stockholders' equity$ 135,441$ 135,458

About Utah Medical Products Inc

UTMD

Utah Medical Products Inc Frequently Asked Questions


What is the ticker symbol for Utah Medical Products Inc? What does UTMD stand for in stocks?

UTMD is the stock ticker symbol of Utah Medical Products Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Utah Medical Products Inc (UTMD)?

As of Fri Jun 14 2024, market cap of Utah Medical Products Inc is 236.9 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of UTMD stock?

You can check UTMD's fair value in chart for subscribers.

What is the fair value of UTMD stock?

You can check UTMD's fair value in chart for subscribers. The fair value of Utah Medical Products Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Utah Medical Products Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for UTMD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Utah Medical Products Inc a good stock to buy?

The fair value guage provides a quick view whether UTMD is over valued or under valued. Whether Utah Medical Products Inc is cheap or expensive depends on the assumptions which impact Utah Medical Products Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for UTMD.

What is Utah Medical Products Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jun 14 2024, UTMD's PE ratio (Price to Earnings) is 14.46 and Price to Sales (PS) ratio is 4.83. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. UTMD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Utah Medical Products Inc's stock?

In the past 10 years, Utah Medical Products Inc has provided 0.041 (multiply by 100 for percentage) rate of return.